Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Diane Kerstein"'
Autor:
Erika B. Rosenzweig, Matthew Bacchetta, Darryl Abrams, Daniel Brodie, Daphnie Drassinower, Mauer Biscotti, Diane Kerstein
Publikováno v:
ASAIO Journal. 64:e8-e10
Pregnancy is typically contraindicated in Eisenmenger syndrome because of its association with excessively high maternal and fetal morbidity and mortality. Here, we report on our novel approach to successfully managing a 29 year old pregnant woman wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89b3dfdfd0186d8acd3905deed2969d9
https://doi.org/10.1097/mat.0000000000000548
https://doi.org/10.1097/mat.0000000000000548
Autor:
Usha Krishnan, Wyman W. Lai, Bhawna Arya, Diane Kerstein, Denise A. Hayes, Warren A. Zuckerman, Cheng-Shiun Leu
Publikováno v:
Pediatric Cardiology. 37:558-567
Right atrial pressure (RAP) reflects right-sided cardiac hemodynamics and is useful in management of patients with cardiac and systemic disease. Studies in older adults demonstrated that inferior vena cava (IVC) diameter, IVC collapsibility index, he
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e082cd34aeba01d6128ec3d6f42afdbc
https://doi.org/10.1007/s00246-015-1315-1
https://doi.org/10.1007/s00246-015-1315-1
Autor:
Diane Kerstein, Marc E. Richmond, Alejandro Torres, Joanne S. Chiu, Usha Krishnan, Julie A. Vincent, Mariel E. Turner, Erika B. Rosenzweig, Warren A. Zuckerman
Publikováno v:
The Journal of Heart and Lung Transplantation. 34:376-380
Background Pulmonary arterial hypertension (PAH) is a progressive disease that, without early identification and treatment, may lead to right heart failure, multi-organ dysfunction and early death. In severe PAH, in addition to maximal medical therap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e177eeef16cb14886b33cff6a03017f
https://doi.org/10.1016/j.healun.2015.01.004
https://doi.org/10.1016/j.healun.2015.01.004
Autor:
Julie A. Vincent, Diane Kerstein, Usha Krishnan, Warren A. Zuckerman, Mariel E. Turner, Alejandro Torres, Erika B. Rosenzweig, Jason Kerstein
Publikováno v:
Pulmonary Circulation. 3:831-839
Cardiac catheterization is important for the management of patients with pulmonary arterial hypertension (PAH). It is used for diagnosis, assessment, and monitoring of PAH patients, as well as to perform interventions such as balloon atrial septostom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::15cec51d7faa05c6d741848d07fcd253
https://doi.org/10.1086/674752
https://doi.org/10.1086/674752
Publikováno v:
The American Journal of Cardiology. 105:1485-1489
Before 2001, intravenous epoprostenol was the only approved drug for patients with idiopathic pulmonary arterial hypertension (IPAH) or familial pulmonary arterial hypertension (FPAH) who were nonresponsive to high-dose calcium channel blockade. The
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc3740ef5217846c3477a98614286b1d
https://doi.org/10.1016/j.amjcard.2009.12.075
https://doi.org/10.1016/j.amjcard.2009.12.075
Publikováno v:
Circulation. 99:1858-1865
Background —Although long-term prostacyclin (PGI2) has been shown to improve hemodynamics, quality of life, and survival in patients with primary pulmonary hypertension, its use in patients with pulmonary hypertension (PHT) and associated congenita
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cadf897077ea8a4e3b85e23dade8599
https://doi.org/10.1161/01.cir.99.14.1858
https://doi.org/10.1161/01.cir.99.14.1858
Publikováno v:
Circulation. 118
Introduction : Prior to the availability of oral/inhaled (inh) PAH drugs, i.e. 2001–2007, IV epoprostenol (EPO) was the only approved drug for pts un-responsive to calcium channel blockade (CCB). We report our experience transitioning selected pedi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7c4bff5e932d7fe83fa6f8a2ee53ef31
https://doi.org/10.1161/circ.118.suppl_18.s_877-b
https://doi.org/10.1161/circ.118.suppl_18.s_877-b
Autor:
Ketevan Berekashvili, Diane Kerstein, Robyn J. Barst, Erika B. Rosenzweig, Rochelle L. Goldsmith, Steven M. Kawut, Allison C. Widlitz, Robert P. Garofano, Evelyn M. Horn
Publikováno v:
The American journal of cardiology. 95(2)
Idiopathic pulmonary arterial hypertension (PAH) is a rare disease with a poor prognosis. New therapies have improved the outcome of this condition; accordingly, the factors that determine outcome may have changed. We aimed to identify determinants o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::de86cf3e304122c2f954000d7f1435f5
https://pubmed.ncbi.nlm.nih.gov/16125507
https://pubmed.ncbi.nlm.nih.gov/16125507
Autor:
Welton M. Gersony, Robyn J. Barst, Daphne T. Hsu, Allan J. Hordof, Paul S. Levy, Diane Kerstein
Publikováno v:
Circulation. 91(7)
Background Patients with severe primary pulmonary hypertension have a poor prognosis, but those with a patent foramen ovale may survive longer. A few reports of clinical improvement after blade balloon atrial septostomy in patients with severe pulmon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d65d5ada9f8d0fed62f06c16fe119208
https://pubmed.ncbi.nlm.nih.gov/7534664
https://pubmed.ncbi.nlm.nih.gov/7534664
Publikováno v:
American journal of diseases of children (1960). 146(8)
•Objective. —To assess the pulmonary function of children with asthma at the time of a routine follow-up visit when they were judged to be clinically well. Design. —Pulmonary function tests were performed on children with a previous diagnosis o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb7eb8085c42d28c85729866780d54e4
https://pubmed.ncbi.nlm.nih.gov/1636669
https://pubmed.ncbi.nlm.nih.gov/1636669